The United States specialty generics market reached an impressive valuation of approximately USD 26.28 billion in 2023. Driven by factors such as cost-effective healthcare solutions, patent expirations, and the growing demand for generic drugs, the market is poised for significant growth. According to expert forecasts, the market is expected to expand at a robust compound annual growth rate...
English
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Romaian
Portuguese (Brazil)